Phase 1-ready biotech developing stem cell therapies for various indications.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/09/2022 |
Offer Price | |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 1.0 |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 1.0 |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
RBW Capital Partners |
Company Data | |
---|---|
Headquarters | Denver, CO, United States |
Founded | 1986 |
Employees at IPO | 10 |
Website www.vitrobiopharma.com |